Trial Outcomes & Findings for Effect of Head and Gaze Position on Soft Toric Contact Lens Performance (NCT NCT01579045)
NCT ID: NCT01579045
Last Updated: 2018-06-19
Results Overview
rotation from zero position also described as absolute value of the rotation.
COMPLETED
NA
24 participants
up to 60 minutes in recumbent position
2018-06-19
Participant Flow
Subjects were recruited and screened based on the inclusion/exclusion criteria.
Participant milestones
| Measure |
All Subjects
All subjects who were enrolled.
|
|---|---|
|
Overall Study
STARTED
|
24
|
|
Overall Study
COMPLETED
|
24
|
|
Overall Study
NOT COMPLETED
|
0
|
Reasons for withdrawal
Withdrawal data not reported
Baseline Characteristics
Effect of Head and Gaze Position on Soft Toric Contact Lens Performance
Baseline characteristics by cohort
| Measure |
Overall Subjects
n=24 Participants
All subjects who were enrolled, and completed the study.
|
|---|---|
|
Age, Continuous
|
43.2 years
STANDARD_DEVIATION 15.3 • n=5 Participants
|
|
Sex: Female, Male
Female
|
21 Participants
n=5 Participants
|
|
Sex: Female, Male
Male
|
3 Participants
n=5 Participants
|
|
Region of Enrollment
United Kingdom
|
24 participants
n=5 Participants
|
PRIMARY outcome
Timeframe: up to 60 minutes in recumbent positionPopulation: Subjects analyzed were those enrolled, randomized, and whom completed the study.
rotation from zero position also described as absolute value of the rotation.
Outcome measures
| Measure |
Senofilcon A (AOfA)
n=24 Participants
As this was a non-dispensing study, the study lenses were worn only during the duration of the visit. Study lenses were marked with a non-toxic marker (e.g. surgical pen) prior to use to aid identification of the lens orientation markers. Each subject wore sequentially the 5 study lenses in a bilateral and random fashion at two different visits.
|
Filcon II 3 (Sauflon)
n=24 Participants
As this was a non-dispensing study, the study lenses were worn only during the duration of the visit. Study lenses were marked with a non-toxic marker (e.g. surgical pen) prior to use to aid identification of the lens orientation markers. Each subject wore sequentially the 5 study lenses in a bilateral and random fashion at two different visits.
|
Etafilcon A (1DAMfA)
n=24 Participants
As this was a non-dispensing study, the study lenses were worn only during the duration of the visit. Study lenses were marked with a non-toxic marker (e.g. surgical pen) prior to use to aid identification of the lens orientation markers. Each subject wore sequentially the 5 study lenses in a bilateral and random fashion at two different visits.
|
Filcon II 3 (C1DT)
n=24 Participants
As this was a non-dispensing study, the study lenses were worn only during the duration of the visit. Study lenses were marked with a non-toxic marker (e.g. surgical pen) prior to use to aid identification of the lens orientation markers. Each subject wore sequentially the 5 study lenses in a bilateral and random fashion at two different visits.
|
Nelfilcon A (FDT)
n=24 Participants
As this was a non-dispensing study, the study lenses were worn only during the duration of the visit. Study lenses were marked with a non-toxic marker (e.g. surgical pen) prior to use to aid identification of the lens orientation markers. Each subject wore sequentially the 5 study lenses in a bilateral and random fashion at two different visits.
|
|---|---|---|---|---|---|
|
Lens Orientation in Recumbent Position
|
15.8 degrees
Interval 11.23 to 20.44
|
35.2 degrees
Interval 30.62 to 39.79
|
19.4 degrees
Interval 14.6 to 24.22
|
29.1 degrees
Interval 24.23 to 33.95
|
21.7 degrees
Interval 16.86 to 26.48
|
SECONDARY outcome
Timeframe: up to 60 minutes in recumbent positionPopulation: Analysis is on those who were enrolled, randomized, and whom completed the study.
Visual Acuity measured in LogMAR units. High contrast visual acuity (VA) was measured in both eyes using a 3m LogMAR test chart at 2.5m testing distance (subsequently converted).
Outcome measures
| Measure |
Senofilcon A (AOfA)
n=24 Participants
As this was a non-dispensing study, the study lenses were worn only during the duration of the visit. Study lenses were marked with a non-toxic marker (e.g. surgical pen) prior to use to aid identification of the lens orientation markers. Each subject wore sequentially the 5 study lenses in a bilateral and random fashion at two different visits.
|
Filcon II 3 (Sauflon)
n=24 Participants
As this was a non-dispensing study, the study lenses were worn only during the duration of the visit. Study lenses were marked with a non-toxic marker (e.g. surgical pen) prior to use to aid identification of the lens orientation markers. Each subject wore sequentially the 5 study lenses in a bilateral and random fashion at two different visits.
|
Etafilcon A (1DAMfA)
n=24 Participants
As this was a non-dispensing study, the study lenses were worn only during the duration of the visit. Study lenses were marked with a non-toxic marker (e.g. surgical pen) prior to use to aid identification of the lens orientation markers. Each subject wore sequentially the 5 study lenses in a bilateral and random fashion at two different visits.
|
Filcon II 3 (C1DT)
n=24 Participants
As this was a non-dispensing study, the study lenses were worn only during the duration of the visit. Study lenses were marked with a non-toxic marker (e.g. surgical pen) prior to use to aid identification of the lens orientation markers. Each subject wore sequentially the 5 study lenses in a bilateral and random fashion at two different visits.
|
Nelfilcon A (FDT)
n=24 Participants
As this was a non-dispensing study, the study lenses were worn only during the duration of the visit. Study lenses were marked with a non-toxic marker (e.g. surgical pen) prior to use to aid identification of the lens orientation markers. Each subject wore sequentially the 5 study lenses in a bilateral and random fashion at two different visits.
|
|---|---|---|---|---|---|
|
Monocular Visual Acuity in Recumbent Position
|
-0.008 units on a scale (LogMAR)
Interval -0.044 to 0.029
|
0.041 units on a scale (LogMAR)
Interval 0.005 to 0.077
|
0.024 units on a scale (LogMAR)
Interval -0.008 to 0.055
|
0.081 units on a scale (LogMAR)
Interval 0.049 to 0.114
|
-0.013 units on a scale (LogMAR)
Interval -0.045 to 0.019
|
Adverse Events
Senofilcon A (AOfA)
Filcon II 3 (Sauflon)
Etafilcon A (1DAMfA)
Filcon II 3 (C1DT)
Nelfilcon A (FDT)
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Katherine Osborn Lorenz, OD MS
Vistakon/Johnson & Johnson Vision Care
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place
Restriction type: LTE60